ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2001

Primary Completion Date

May 31, 2002

Study Completion Date

August 31, 2005

Conditions
Kidney Cancer
Interventions
DRUG

gefitinib

Trial Locations (2)

21201

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

Veterans Affairs Medical Center - Baltimore, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

University of Maryland Greenebaum Cancer Center

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT00014183 - ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer | Biotech Hunter | Biotech Hunter